During this discussion about healthcare spending, the panelists debate whether or not current spending is proportional to the current improvements in patient outcomes.
David Calabrese, RPh, MHP, is not convinced that spending and patient outcomes are proportional, and explains that although there have been modest improvements, he feels that from a managed care standpoint factors such as the aging population are of concern.
Agreeing with Mr Calabrese, Kenneth L. Schaecher, MD, FACP, CPC, states that the debate remains that patients are getting the same value of care in relation to the dollars being spent. Dr Schaecher explains that a healthcare misalignment exists because the price of drugs keeps rising. Dr Schaecher continues by saying that pharmaceutical companies are doing their job and are bringing drugs to the market to treat conditions; however, the prices are rising because of the financial demands of their investors.
Yehuda Handelsman, MD, FACP, FACE, FNLA, concludes that issues remain, and feels that a 2-tier system may become necessary in this country to help preserve medical care.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Impact of Hospital-Physician Integration on Medicare Patient Mix
April 11th 2025This study found no evidence that hospital employment of physicians resulted in physicians treating sicker patients, undercutting claims that hospital-employed physicians serve a higher-acuity patient mix.
Read More